By Jenny Bryan2000-11-30T00:00:00
The huge rise in the type-2 diabetes population - and the introduction of major new drug treatments - is set to pose some increasingly tough management decisions, writes Jenny Bryan
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud